Debiopharm Innovation Fund

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Debiopharm Innovation Fund — overview

Type

Private Equity Firm

Location

Lausanne Switzerland

Alternative Asset Class

-

Established

2006

Firm Ownership

Captive Arm – Corporate

Investment Team Staff

Total Staff

-

About

Debiopharm Innovation Fund is the corporate venture capital arm of Debiopharm Group, headquartered in Lausanne, Switzerland. The firm seeks to invest in companies developing smart data technologies for drug development, digital health, and patient digitisation.

Want to see more?

Request a demo for full access to this profile.

Fund manager advanced search

Performance track records at your fingertips

Access effective, reliable, and comparable fund performance data and place your firm or portfolio within the context of the alternative assets market.

With data and benchmarks that track back more than 40 years, Preqin Pro is the most trusted data provider in the industry.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.